SF3B1, RUNX1 and TP53 Mutations Significantly Impact the Outcome of Patients with Lower-Risk Myelodysplastic Syndrome
| Autor: | Falantes, Jose F. *, Márquez-Malaver, Francisco J. *, Carrillo-Cruz, Estrella *, Morales-Camacho, Rosario M *, Prats-Martín, Concepción *, Caballero, Teresa *, Rodriguez Arbolí, Eduardo *, Espigado, Ildefonso, Perez-Simon, Jose A. |
|---|---|
| Zdroj: | In Blood 15 November 2022 140 Supplement 1:6920-6922 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|